New York bills · 2025 Regular Session

New York S 6937

Limits the substitution of abuse-deterrent analgesic opioid drug products for analgesic opioids lacking such technology

Introduced
In committee
Passed Senate
Passed House
To Governor
Became law

Sponsors

Andrew J. Lanza (Republican/Conservative/Independence/Reform)

Summary

Official abstract published by the New York legislature

Provides for patient access to FDA approved abuse-deterrent technology to help combat opioid abuse.

Text versions

S6937

Roll-call votes

No recorded votes on this bill.

Actions

Jan 7, 2026 · Senate
REFERRED TO INSURANCE
Mar 27, 2025 · Senate
REFERRED TO INSURANCE